Group | Before treatment | At the 1 month | At the 3 months | At the 18 months | Last follow-up |
---|
Group A | 71.52 ± 14.85 | 30.54 ± 9.15 | 15.37 ± 3.17 | 10.56 ± 2.35 | 9.32 ± 2.07 |
Group B | 73.23 ± 18.79 | 20.20 ± 8.65 | 10.05 ± 2.44 | 9.87 ± 2.61 | 8.81 ± 1.75 |
P value | 0.954a | 0.036b | 0.738c | 0.655d | 0.712e |
- a There was no significant difference in ESR before treatment between the two groups (Repeated measure analysis, p > 0.05)
- b There was significant difference in ESR at the 1 month of treatment between the two groups (Repeated measure analysis, p < 0.05)
- c There was no significant difference in ESR at the 3 months of treatment between the two groups (Repeated measure analysis, p > 0.05)
- d There was no significant difference in ESR at the 18 months of treatment between the two groups (Repeated measure analysis, p > 0.05)
- e There was no significant difference in ESR at the last follow-up between the two groups (Repeated measure analysis, p > 0.05)